Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study
CONCLUSION: The MenACWY conjugate vaccine was immunogenic in the vast majority of JIA and IBD patients at adolescent age, but seroprotection was lower in patients using anti-TNF agents. Therefore, an extra booster MenACWY vaccination should be considered.PMID:37198018 | DOI:10.1016/j.vaccine.2023.04.056
Source: Vaccine - Category: Allergy & Immunology Authors: Milou Ohm Joeri W van Straalen Marieke Zijlstra Gerrie de Joode-Smink Anne Jasmijn Sellies Joost F Swart Sebastiaan J Vastert Joris M van Montfrans Marije Bartels Annet van Royen-Kerkhof Joanne G Wildenbeest Caroline A Lindemans Victorien Wolters Roos A W Source Type: research
More News: Allergy & Immunology | Arthritis | Inflammatory Bowel Disease | Men | Meningitis | Meningitis Vaccine | Netherlands Health | Rheumatology | Study | Vaccines